Association of mitral annulus calcification with high-sensitivity C-reactive protein, which is a marker of

Ertuğrul Kurtoğlu1, Hasan Korkmaz, Erdal Aktürk

  • 1Department of Cardiology, Elazığ Education and Research Hospital, 23100 Elazığ, Turkey. erkurtoglu@hotmail.com

Insights

Mitral annular calcification (MAC) is associated with higher levels of high-sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation. This finding suggests a link between MAC and inflammation, even in patients without other common risk factors.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Diagnostic Markers

Background:

  • Limited clinical data exists on the relationship between mitral annular calcification (MAC) and systemic inflammation.
  • Systemic inflammation plays a role in various cardiovascular diseases.

Purpose of the Study:

  • To compare high-sensitivity C-reactive protein (hs-CRP) levels in patients with and without MAC.
  • To investigate the association between MAC and hs-CRP levels.

Main Methods:

  • A case-control study involving 100 patients with MAC and 100 age-matched controls without MAC.
  • Transthoracic echocardiography (TTE) was used for MAC assessment.
  • Hs-CRP levels were measured and compared between the two groups.

Main Results:

  • Patients with MAC had significantly higher hs-CRP levels compared to controls (2.02 ± 0.35 vs. 1.43 ± 0.47 mg/dl, P < 0.001).
  • The MAC group showed a higher prevalence of female gender, hypertension, and coronary artery disease.
  • Elevated hs-CRP in the MAC group was observed even in subgroups without hypertension, coronary artery disease, or in male patients.

Conclusions:

  • Hs-CRP, a sensitive marker of systemic inflammation, is increased in patients with mitral annular calcification.
  • This study highlights a potential link between MAC and underlying systemic inflammation.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...